Diffuse Alveolar Hemorrhage



Diffuse Alveolar Hemorrhage


Amber A. Afshar

Richard D. Brasington



General Principles



  • Diffuse alveolar hemorrhage (DAH) encompasses a heterogeneous group of pulmonary and nonpulmonary disorders characterized by widespread intra-alveolar bleeding.


  • DAH is a medical emergency that can result in acute respiratory failure and death.


  • The exact incidence and prevalence of DAH are unknown owing to the variety of underlying etiologies but the most common cause of DAH appears to be systemic vasculitis, in particular granulomatosis with polyangiitis (GPA) (Fig. 19-1).1,2


  • The pathogenesis of DAH is thought to be secondary to direct effects of autoantibodies on the alveolar capillary endothelium.


  • Differentiation from localized etiologies (Table 19-1) of pulmonary hemorrhage is difficult to ascertain on history and physical examination alone; diagnostic procedures such as CXR and fiberoptic bronchoscopy are often needed.






FIGURE 19-1. Causes of diffuse alveolar hemorrhage. ABMA, antibasement membrane antibody–mediated disease; CTD, connective tissue disease; IPH, idiopathic pulmonary hemorrhage; PRS, pulmonary renal syndromes. (Data from Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol. 1990;14:1112–25.)









TABLE 19-1 CAUSES OF LOCALIZED PULMONARY HEMORRHAGE




















Upper airway or gastrointestinal bleeding with resultant aspiration—that is, epistaxis or hematemesis (may be difficult to distinguish from diffuse alveolar hemorrhage)
Neoplasm (primary bronchogenic, Kaposi sarcoma)
Cavitary lung disease (secondary to TB, aspergillosis)
Pulmonary infarction
Bronchitis
Bronchiectasis
Broncholithiasis
Necrotizing bronchopneumonia
Arteriovenous malformations


Diagnosis



  • Appropriate diagnosis of DAH requires high clinical suspicion and a thorough history and physical examination.


  • Rapid diagnosis of DAH is mandatory given the potential for excessive morbidity (renal failure, restrictive and obstructive lung disease) and mortality rates approaching 70–80% in untreated subsets of patients.


Clinical Presentation



  • DAH should be suspected whenever a patient presents with hemoptysis, dyspnea, and a predisposing condition, such as an underlying connective tissue disorder, systemic vasculitis, or certain drug or occupational exposures.


  • Hemoptysis, a presumed cardinal symptom of DAH, may be absent in up to one-third of cases despite pronounced and life-threatening alveolar hemorrhage.


  • A detailed history of past and present medications (prescribed, over-the-counter, and recreational) and occupational exposures should be obtained.



    • Amiodarone, retinoic acid, sirolimus, penicillamine, and crack cocaine have all been implicated as causative agents of DAH.3


    • Inhalation of trimellitic anhydride, a chemical found in paints, varnishes, and plastics, has also been reported as a cause of DAH.


  • Physical examination findings are nonspecific and may include fever, hypoxemia, tachypnea, and diffuse crackles.


  • Signs suggesting an underlying systemic disorder should be sought. These signs may include sinusitis, iritis, oral ulcers, arthritis, synovitis, palpable purpura, neuropathy, and cardiac murmurs.


Differential Diagnosis

DAH is infrequently the initial presentation of an underlying systemic disorder (Table 19-2 and Fig. 19-1).1,2,3,4,5,6,7,8,9,10,11,12,13,14 Twenty percent of patients with systemic lupus erythematosus (SLE) and 5–10% of patients with Goodpasture syndrome present with DAH as the initial or sole manifestation. Therefore, emphasis should be placed on the rheumatologic, renal, pulmonary, and cardiac review of systems.


Diagnostic Testing


Laboratories



  • Laboratory evaluation is crucial for the diagnosis of DAH.


  • Complete blood count









    TABLE 19-2 CAUSES OF DIFFUSE ALVEOLAR HEMORRHAGE








    Rheumatologic
        Systemic lupus erythematosus5
        Rheumatoid arthritis6
        Mixed connective tissue disorder6
        Systemic sclerosis
        Juvenile rheumatoid arthritis
        Polymyositis
    Hematologic
        Autologous or allogeneic stem cell transplant7
        Thrombotic thrombocytopenic purpura8
        Idiopathic thrombocytopenic purpura
        Disseminated intravascular coagulation
        Cryoglobulinemia
        Antiphospholipid antibody syndrome9
        Multiple myeloma
    Vasculitis
        Behçet disease
        Cryoglobulinemia
        Goodpasture syndrome
        Granulomatosis with polyangiitis (Wegener granulomatosis)
        Henoch–Schönlein purpura
        Microscopic polyangiitis
    Pulmonary
        Isolated pauci-immune pulmonary capillaritis
        Idiopathic pulmonary fibrosis
        Idiopathic pulmonary hemosiderosis
        Acute lung transplant rejection
        Pulmonary venoocclusive disease
        Pulmonary capillary hemangiomatosis
    Renal
        IgA nephropathy
        Idiopathic glomerulonephritis
        Poststreptococcal glomerulonephritis
    Cardiac
        Mitral stenosis
        Bacterial endocarditis
    Gastrointestinal
        Ulcerative colitis
    Medication/drugs
        Abciximab10
        Amiodarone11
        Crack cocaine3
        Nitrofurantoin
        Penicillamine
        Propylthiouracil
        Phenytoin
        Retinoic acid12
        Sirolimus13
        Tirofiban10
        Warfarin14
    Occupational exposures
        Trimellitic anhydride
        Radiation exposure
        Asbestosis
        Welder pneumoconiosis

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

Nov 20, 2018 | Posted by in RESPIRATORY | Comments Off on Diffuse Alveolar Hemorrhage

Full access? Get Clinical Tree

Get Clinical Tree app for offline access